AEDT

UiPath Unveils New Family of LLMs at AI Summit to Empower Enterprises to Harness Full Capabilities of GenAI

Retrieved on: 
Tuesday, March 19, 2024

UiPath will showcase its latest capabilities at the virtual AI Summit taking place today, March 19 at 10:00 am GMT, 11:00 am EDT, and 3:00 pm AEDT.

Key Points: 
  • UiPath will showcase its latest capabilities at the virtual AI Summit taking place today, March 19 at 10:00 am GMT, 11:00 am EDT, and 3:00 pm AEDT.
  • “Businesses need an assortment of AI models, the best in class for every task, to achieve their full potential.
  • General-purpose GenAI models like GPT-4 struggle to match the performance and accuracy of models specially trained for a specific task.
  • Context Grounding will enhance all UiPath Gen AI experiences in UiPath Autopilots, GenAI Activities, and intelligent document processing (IDP) products like Document Understanding.

Thriving Through the Energy Transition Investor Presentation

Retrieved on: 
Monday, March 11, 2024

Woodside CEO Meg O’Neill will brief investors on Woodside’s Climate Transition Action Plan (CTAP) and 2023 Progress Report today at 09:30 AEDT / 06:30 AWST / U.S. 17:30 CDT (Monday, 11 March 2024).

Key Points: 
  • Woodside CEO Meg O’Neill will brief investors on Woodside’s Climate Transition Action Plan (CTAP) and 2023 Progress Report today at 09:30 AEDT / 06:30 AWST / U.S. 17:30 CDT (Monday, 11 March 2024).
  • Ms O’Neill said the CTAP contained additional information, requested by investors, about Woodside’s approach to climate change and the energy transition.
  • This complements the existing target to invest $5 billion, in new energy products and lower carbon services by 2030.
  • “I firmly believe Woodside is built to thrive through the energy transition and our Climate Transition Action Plan shows how we plan to achieve this.

Vivid Sydney 2024 Program Unveiled

Retrieved on: 
Monday, March 11, 2024

SYDNEY, AU, Mar 11, 2024 - (ACN Newswire) - Vivid Sydney, the Southern Hemisphere's largest multi-artform festival, today unveiled its captivating program for 2024.

Key Points: 
  • SYDNEY, AU, Mar 11, 2024 - (ACN Newswire) - Vivid Sydney, the Southern Hemisphere's largest multi-artform festival, today unveiled its captivating program for 2024.
  • Australia's largest event will transform Sydney with mesmerising light installations and 3D projections from Circular Quay to The Goods Line; genre-spanning music performances and creative showcases; a formidable Vivid Ideas program featuring experiences that will open minds; and a mouth-watering Vivid Food program.
  • Staged across Sydney, Vivid Sydney festival locations and venues include Circular Quay, the Sydney Opera House, The Rocks, State Library of New South Wales, Walsh Bay, Walsh Bay Arts Precinct, Barangaroo, Darling Harbour, University of Technology Sydney, The Goods Line, Royal Botanic Garden Sydney, Carriageworks, and more.
  • Vivid Sydney 2024 will engage audiences across four pillars: Vivid Light, Vivid Music, Vivid Ideas and Vivid Food.

BLUETTI Launches SwapSolar on Indiegogo, Elevating Your Outdoor Experience

Retrieved on: 
Thursday, February 22, 2024

The SwapSolar is not just a product; it's an answer to your outdoor power needs, ice-making desires, and long-distance travel cooling cravings - all in one.

Key Points: 
  • The SwapSolar is not just a product; it's an answer to your outdoor power needs, ice-making desires, and long-distance travel cooling cravings - all in one.
  • The AC180T ensures your independent outdoor power supply off the grid, while the MultiCooler's 3-in-1 design provides excellent coolness and efficiency.
  • As BLUETTI's spokesperson, James Ray, aptly puts it, "We want users to savor the joy of outdoor life.
  • Power up and keep your food fresh at once, it's time to go wild with BLUETTI!"

Mesoblast Financial Results and Corporate Update Webcast

Retrieved on: 
Monday, February 26, 2024

NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the six months ended December 31, 2023.

Key Points: 
  • NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the six months ended December 31, 2023.
  • The webcast will begin at 5.00pm EST, Wednesday, February 28; 9.00am AEDT, Thursday, February 29, 2024.
  • It can be accessed via: https://webcast.openbriefing.com/msb-hyr-2024/
    The archived webcast will be available on the Investor page of the Company’s website: www.mesoblast.com

AVITA Medical to Host Investor Webinar Briefing

Retrieved on: 
Friday, February 23, 2024

VALENCIA, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, Chief Executive Officer, and David O’Toole, Chief Financial Officer, on February 27, 2024, at 2:00 p.m. (PST) / February 28, 2024, at 9:00 a.m. (AEDT).

Key Points: 
  • VALENCIA, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, Chief Executive Officer, and David O’Toole, Chief Financial Officer, on February 27, 2024, at 2:00 p.m. (PST) / February 28, 2024, at 9:00 a.m. (AEDT).
  • The webinar presentation will cover financial highlights from our recent fourth quarter and full-year 2023 earnings webcast, business highlights, 2024 revenue guidance, and conclude with a Q&A session.
  • To register for the presentation, please follow this Zoom link:

Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline

Retrieved on: 
Thursday, February 22, 2024

MELBOURNE, Australia, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its results for the financial year ended 31 December 2023.

Key Points: 
  • MELBOURNE, Australia, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its results for the financial year ended 31 December 2023.
  • Dr Christian Behrenbruch, Managing Director and Group CEO commented:
    “This is an excellent result which demonstrates the strength of the Telix business model.
  • Full year revenue for 2024 expected range of US$445M to US$465M ($675M to $705M at current exchange rates), representing an approximate 35-40% increase on 2023.
  • Expected additional investment of 40-50% in R&D (compared with 2023), including both external and internal costs funded by operating cash flow and broadly in line with revenue growth.

Alcoa Announces Agreement With Alumina Limited on Terms and Process to Acquire Alumina Limited in All-Stock Transaction

Retrieved on: 
Sunday, February 25, 2024

Alcoa and Alumina Limited have entered into an exclusivity and transaction process deed (“Process Deed”), and the Alumina Limited Board of Directors has confirmed that, subject to entry into a scheme implementation agreement, it intends to recommend the transaction to Alumina Limited shareholders.

Key Points: 
  • Alcoa and Alumina Limited have entered into an exclusivity and transaction process deed (“Process Deed”), and the Alumina Limited Board of Directors has confirmed that, subject to entry into a scheme implementation agreement, it intends to recommend the transaction to Alumina Limited shareholders.
  • Under the all-scrip, or all-stock, transaction, Alumina Limited shareholders would receive consideration of 0.02854 Alcoa shares for each Alumina Limited share (the “Agreed Ratio”).
  • Under the Process Deed, Alcoa and Alumina Limited intend to finalize and enter into a scheme implementation agreement for the all-scrip transaction (the “Agreement”).
  • Upon completion of the Agreement, Alumina Limited shareholders would own 31.25 percent, and Alcoa shareholders would own 68.75 percent of the combined company.1
    Alcoa is the sole operator of Alcoa World Alumina and Chemicals (AWAC), a joint venture (“JV”) with Alumina Limited.

Cenntro Electric Group Limited Announces Approval of the Scheme of Arrangement by the Supreme Court of New South Wales

Retrieved on: 
Friday, February 16, 2024

Cenntro is pleased to announce that the Supreme Court of New South Wales, Australia (the "Court") made orders approving the proposed Scheme on Friday, February 16, 2024 (Australian Eastern Daylight Time, "AEDT").

Key Points: 
  • Cenntro is pleased to announce that the Supreme Court of New South Wales, Australia (the "Court") made orders approving the proposed Scheme on Friday, February 16, 2024 (Australian Eastern Daylight Time, "AEDT").
  • An office copy of the Court orders lodged with ASIC is attached at Annexure A to this press release.
  • Cenntro, in consultation with Cenntro Inc., may vary any or all of these dates and times and will provide reasonable notice of any such variation.
  • Any changes will be announced by Cenntro to Nasdaq and published on Cenntro’s website at www.cenntroauto.com .

Perseus Mining Half Year Results Investor Webinar

Retrieved on: 
Thursday, February 15, 2024

Perth, Western Australia/February 15, 2024/Perseus Mining Limited (ASX/TSX: PRU) is hosting an investor webinar and conference call to discuss its December 2023 Half Year Results, which are anticipated for release around 8:30am AEDT on Friday February 23, 2024.

Key Points: 
  • Perth, Western Australia/February 15, 2024/Perseus Mining Limited (ASX/TSX: PRU) is hosting an investor webinar and conference call to discuss its December 2023 Half Year Results, which are anticipated for release around 8:30am AEDT on Friday February 23, 2024.
  • After registering, you will receive a confirmation email containing information about joining the webinar.
  • To join the webinar via telephone, please use one of the following numbers and enter the Webinar ID: 845 6314 6386
    For higher quality, dial a number based on your current location: